Send us a link
Experts are predicting demand for life-saving antiviral drugs will rapidly outpace supply. Like the vaccine, the poorest countries will be left until last, says medicine access advocate Othoman Mellouk
As pandemic restrictions lift, researchers stress the need to prepare for the next variant
Apart from economic, political, and cultural cooperation for an equal growth of all developing countries, science and technology are an integral significant component in these levels of engagement for leveraging mutual gains. The current pandemic not only brought about an 1800 shift in the relationship between the government, policy makers, and the scientific community but highlights the importance of South–South Cooperation (SSC).
COVID-19 presents a opportunity to transform democratic engagement in the governance of global public goods. To make us more resistant and resilient to future global health crises we need transformative thinking to democratically engage global citizens.
Too many national leaders get good guidance yet make poor decisions.
A healthcare center widely sharing its internal guidelines on how to treat COVID-19 patients "just wasn't done." As the pandemic raged at a Boston hospital, the next generation of clinical leaders pushed for change.
Thirteen of the 17 members of Poland's Medical Council advising the prime minister on COVID-19 resigned on Friday, condemning what they said was a lack of scientific influence on policy.
Young scientists provide advice to a researcher, who feels left behind after a difficult pandemic experience.
A new COVID-19 vaccine, developed by researchers from the Texas Children's Hospital and Baylor College of Medicine, is being offered patent-free to vaccine manufacturers across the world.
B.1.640.2 was discovered in a traveler returning from Cameroon and has a high number of mutations. And a first "flurona" case has been confirmed in Israel.
Africa urgently needs to guarantee its own health security.
The island nation struggles to keep the lights on but has inoculated 90% of its population with home-developed vaccines
In December 2019 the WHO was told of a cluster of pneumonia cases in Wuhan, China. These charts show how Covid-19 has spread across the world since then
The COVID-19 pandemic has led to a “second pandemic” of anxiety and depression. While vaccines are primarily aimed at reducing COVID-19 transmission and mortality risks, they may have important secondary benefits.
The extraordinary vaccination of more than four billion people, and the lack of access for many others, were major forces this year - while Omicron's arrival complicated things further.
The European Medicines Agency has approved the Novavax coronavirus vaccine. The protein-based vaccine may be a real alternative, both for bringing forward the global vaccination campaign, and for vaccination skeptics.
Analysis: scientists are only starting to understand new COVID mutation but there is encouraging news from the laboratory, South Africa and on antiviral drugs.
A patent waiver will not help guarantee COVID-19 vaccines equity around the world and instead richer countries should back compulsory licensing, says a new report by the European Federation of Academies of Sciences and Humanities (ALLEA).
Political leaders in Florida and Missouri are opting to censor scientists and bury COVID-19 data rather than use that data to protect people in their states. In Florida, state officials pressured researchers at the University of Florida to destroy COVID-19 data and prevented them from accessing stat
Millions have died unnecessarily and millions more will in 2022 unless something changes, says Anthony Costello, former WHO director
UK faces a grim winter if vaccines offer poor overall protection, but if the virus has weak powers to evade immunity, hospital cases can be contained.
Various studies show people have better immune responses and produce more antibodies with a combination of the AstraZeneca, BioNTech or Moderna vaccines.
COVID researchers are working at breakneck speed to learn about the variant's transmissibility, severity and ability to evade vaccines.
The data are growing that booster jabs enhance protection - but their durability, impact and ability to quash the new variant are unknown.
Anthony Fauci on four decades of progress against HIV, and what's needed for the future.
